Catalyst Capital Advisors’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
Other funds holding AGN
LP
BG
Catalyst Capital Advisors's AGN Position: Q4 2018 in Review
Catalyst Capital Advisors sold out of Allergan plc (AGN) in Q4 2018, closing a stake of 4,100 shares — an estimated $781K sold.
Catalyst Capital Advisors first reported a position in AGN in Q2 2013 and held it in 16 quarters. The position peaked at $5.2M in Q4 2015. 1,007 funds tracked by Wall St. Rank hold AGN as of Q4 2018.
- Catalyst Capital Advisors reported no remaining Allergan plc position as of Q4 2018 after selling out during the quarter.
- Catalyst Capital Advisors sold 4,100 Allergan plc shares in Q4 2018, an estimated $781K.
- Catalyst Capital Advisors first reported a position in Allergan plc in Q2 2013 and held it in 16 quarters.
- Catalyst Capital Advisors's Allergan plc position peaked at $5.2M in Q4 2015.
- 1,007 funds tracked by Wall St. Rank held Allergan plc as of Q4 2018.
Based on Catalyst Capital Advisors's 13F filing for Q4 2018, filed 7 Feb 2019.